This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
27 Jan 2022
MAHSC Seminar Series: ‘COVID-19 – Effects & Behavioural Science’
![Covid-19](https://healthinnovationmanchester.com/wp-content/uploads/2022/01/COVID-19-Square.jpg)
Manchester Academic Health Science Centre (MAHSC) is a partnership between The University of Manchester, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, Salford Royal NHS Foundation Trust (part of the Northern Care Alliance), and Greater Manchester Mental Health NHS Foundation Trust to unite leading healthcare providers with world-class academics and researchers.
In April 2020, Manchester Academic Health Science Centre (MAHSC), part of Health Innovation Manchester, was officially designated by National Institute for Health Research (NIHR), NHS England and NHS Improvement up to 2025. The MAHSC Seminar Series showcases the great discovery and clinical science being undertaken within Manchester and its impact on the health of the local population.
The series gives a local platform to the nationally and internationally renowned scientists of MAHSC to share their work with clinical, non-clinical, university colleagues, but also crucially members of the wider community seeking insight into innovations in the delivery of healthcare.
This month’s seminar was on ‘COVID-19 effects on people with diabetes and behavioural science approaches to the pandemic.’ The seminar was chaired by Prof Darren Ashcroft, NIHR Greater Manchester Patient Safety Translational Research Centre (PSTRC)
Dr. Matthew Carr (Research Fellow, NIHR Greater Manchester PSTRC) delivered a presentation on ‘Effects of the COVID-19 pandemic on people with diabetes: findings from population-based cohorts studies‘ It was explained that in the first few months of the pandemic almost a third of the COVID-19 related deaths were individuals who also had diabetes. As the data was limited to the Greater Manchester area they devised a research programme which was split into 3 phases starting in March 2020.
Prof Christopher Armitage (Lead for Behavioural Sciences, NIHR Greater Manchester PSTRC) spoke on ‘Behavioural science approaches to the COVID-19 pandemic’ and he addressed why behavioural science approaches are needed for any type of health problem.
Watch session here:
MAHSC Seminar Series: ‘COVID-19 – Effects & Behavioural Science’